Logo image of PFE.DE

PFIZER INC (PFE.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:PFE - US7170811035 - Common Stock

21.9 EUR
-0.05 (-0.23%)
Last: 1/15/2026, 7:00:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to PFE. PFE was compared to 53 industry peers in the Pharmaceuticals industry. While PFE is still in line with the averages on profitability rating, there are concerns on its financial health. PFE is valued quite cheap, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

  • PFE had positive earnings in the past year.
  • In the past year PFE had a positive cash flow from operations.
  • In the past 5 years PFE has always been profitable.
  • PFE had a positive operating cash flow in each of the past 5 years.
PFE.DE Yearly Net Income VS EBIT VS OCF VS FCFPFE.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B

1.2 Ratios

  • PFE's Return On Assets of 4.71% is in line compared to the rest of the industry. PFE outperforms 43.40% of its industry peers.
  • PFE has a Return On Equity (10.59%) which is in line with its industry peers.
  • PFE has a Return On Invested Capital of 7.47%. This is comparable to the rest of the industry: PFE outperforms 49.06% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for PFE is below the industry average of 14.02%.
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROIC 7.47%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
PFE.DE Yearly ROA, ROE, ROICPFE.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

1.3 Margins

  • With a decent Profit Margin value of 15.65%, PFE is doing good in the industry, outperforming 60.38% of the companies in the same industry.
  • In the last couple of years the Profit Margin of PFE has declined.
  • PFE has a better Operating Margin (29.12%) than 75.47% of its industry peers.
  • In the last couple of years the Operating Margin of PFE has grown nicely.
  • With a decent Gross Margin value of 74.95%, PFE is doing good in the industry, outperforming 71.70% of the companies in the same industry.
  • In the last couple of years the Gross Margin of PFE has declined.
Industry RankSector Rank
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
PFE.DE Yearly Profit, Operating, Gross MarginsPFE.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so PFE is still creating some value.
  • Compared to 1 year ago, PFE has more shares outstanding
  • The number of shares outstanding for PFE has been increased compared to 5 years ago.
  • The debt/assets ratio for PFE has been reduced compared to a year ago.
PFE.DE Yearly Shares OutstandingPFE.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B
PFE.DE Yearly Total Debt VS Total AssetsPFE.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B

2.2 Solvency

  • An Altman-Z score of 2.21 indicates that PFE is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • PFE has a Altman-Z score of 2.21. This is comparable to the rest of the industry: PFE outperforms 43.40% of its industry peers.
  • PFE has a debt to FCF ratio of 5.95. This is a neutral value as PFE would need 5.95 years to pay back of all of its debts.
  • PFE has a Debt to FCF ratio of 5.95. This is comparable to the rest of the industry: PFE outperforms 52.83% of its industry peers.
  • PFE has a Debt/Equity ratio of 0.62. This is a neutral value indicating PFE is somewhat dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.62, PFE is in line with its industry, outperforming 47.17% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Altman-Z 2.21
ROIC/WACC0.88
WACC8.52%
PFE.DE Yearly LT Debt VS Equity VS FCFPFE.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B 80B

2.3 Liquidity

  • A Current Ratio of 1.28 indicates that PFE should not have too much problems paying its short term obligations.
  • The Current ratio of PFE (1.28) is comparable to the rest of the industry.
  • A Quick Ratio of 0.97 indicates that PFE may have some problems paying its short term obligations.
  • PFE has a Quick ratio (0.97) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.28
Quick Ratio 0.97
PFE.DE Yearly Current Assets VS Current LiabilitesPFE.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

  • PFE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 24.03%, which is quite impressive.
  • The Earnings Per Share has been growing slightly by 1.06% on average over the past years.
  • PFE shows a small growth in Revenue. In the last year, the Revenue has grown by 3.90%.
  • Measured over the past years, PFE shows a quite strong growth in Revenue. The Revenue has been growing by 9.10% on average per year.
EPS 1Y (TTM)24.03%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%-17.92%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-5.92%

3.2 Future

  • Based on estimates for the next years, PFE will show a decrease in Earnings Per Share. The EPS will decrease by -5.87% on average per year.
  • PFE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -3.45% yearly.
EPS Next Y1.34%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
EPS Next 5Y-5.87%
Revenue Next Year-1.36%
Revenue Next 2Y-1.53%
Revenue Next 3Y-2.16%
Revenue Next 5Y-3.45%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
PFE.DE Yearly Revenue VS EstimatesPFE.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20B 40B 60B 80B 100B
PFE.DE Yearly EPS VS EstimatesPFE.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 7.96 indicates a rather cheap valuation of PFE.
  • 92.45% of the companies in the same industry are more expensive than PFE, based on the Price/Earnings ratio.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, PFE is valued rather cheaply.
  • Based on the Price/Forward Earnings ratio of 8.40, the valuation of PFE can be described as reasonable.
  • Based on the Price/Forward Earnings ratio, PFE is valued cheaply inside the industry as 94.34% of the companies are valued more expensively.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 24.31, PFE is valued rather cheaply.
Industry RankSector Rank
PE 7.96
Fwd PE 8.4
PFE.DE Price Earnings VS Forward Price EarningsPFE.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • PFE's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. PFE is cheaper than 86.79% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, PFE is valued cheaper than 83.02% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.98
EV/EBITDA 7.14
PFE.DE Per share dataPFE.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates PFE does not grow enough to justify the current Price/Earnings ratio.
  • A cheap valuation may be justified as PFE's earnings are expected to decrease with -2.35% in the coming years.
PEG (NY)5.95
PEG (5Y)7.5
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 6.80%, PFE is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 1.72, PFE pays a better dividend. On top of this PFE pays more dividend than 100.00% of the companies listed in the same industry.
  • PFE's Dividend Yield is rather good when compared to the S&P500 average which is at 1.92.
Industry RankSector Rank
Dividend Yield 6.8%

5.2 History

  • The dividend of PFE has a limited annual growth rate of 3.30%.
Dividend Growth(5Y)3.3%
Div Incr Years3
Div Non Decr Years3
PFE.DE Yearly Dividends per sharePFE.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 98.76% of the earnings are spent on dividend by PFE. This is not a sustainable payout ratio.
  • PFE's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP98.76%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
PFE.DE Yearly Income VS Free CF VS DividendPFE.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B
PFE.DE Dividend Payout.PFE.DE Dividend Payout, showing the Payout Ratio.PFE.DE Dividend Payout.PayoutRetained Earnings

PFIZER INC

FRA:PFE (1/15/2026, 7:00:00 PM)

21.9

-0.05 (-0.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)11-04
Earnings (Next)02-03
Inst Owners67.61%
Inst Owner ChangeN/A
Ins Owners0.02%
Ins Owner ChangeN/A
Market Cap124.52B
Revenue(TTM)62.79B
Net Income(TTM)9.83B
Analysts70.91
Price Target25.24 (15.25%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.8%
Yearly Dividend1.44
Dividend Growth(5Y)3.3%
DP98.76%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)34.46%
Min EPS beat(2)32.91%
Max EPS beat(2)36.01%
EPS beat(4)4
Avg EPS beat(4)34.72%
Min EPS beat(4)32.52%
Max EPS beat(4)37.45%
EPS beat(8)8
Avg EPS beat(8)54.91%
EPS beat(12)12
Avg EPS beat(12)44.86%
EPS beat(16)16
Avg EPS beat(16)38.4%
Revenue beat(2)1
Avg Revenue beat(2)3.22%
Min Revenue beat(2)-0.53%
Max Revenue beat(2)6.96%
Revenue beat(4)2
Avg Revenue beat(4)1.35%
Min Revenue beat(4)-2.36%
Max Revenue beat(4)6.96%
Revenue beat(8)5
Avg Revenue beat(8)3.39%
Revenue beat(12)7
Avg Revenue beat(12)2.76%
Revenue beat(16)10
Avg Revenue beat(16)3.12%
PT rev (1m)-0.22%
PT rev (3m)-1.01%
EPS NQ rev (1m)-5.21%
EPS NQ rev (3m)-19.51%
EPS NY rev (1m)-0.67%
EPS NY rev (3m)0.67%
Revenue NQ rev (1m)-1.74%
Revenue NQ rev (3m)-3.03%
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.64%
Valuation
Industry RankSector Rank
PE 7.96
Fwd PE 8.4
P/S 2.31
P/FCF 13.98
P/OCF 11.09
P/B 1.56
P/tB N/A
EV/EBITDA 7.14
EPS(TTM)2.75
EY12.56%
EPS(NY)2.61
Fwd EY11.91%
FCF(TTM)1.57
FCFY7.15%
OCF(TTM)1.97
OCFY9.01%
SpS9.48
BVpS14.01
TBVpS-4.17
PEG (NY)5.95
PEG (5Y)7.5
Graham Number29.44
Profitability
Industry RankSector Rank
ROA 4.71%
ROE 10.59%
ROCE 10.62%
ROIC 7.47%
ROICexc 8.19%
ROICexgc 34.99%
OM 29.12%
PM (TTM) 15.65%
GM 74.95%
FCFM 16.53%
ROA(3y)6.87%
ROA(5y)7.73%
ROE(3y)14.76%
ROE(5y)17.45%
ROIC(3y)10.06%
ROIC(5y)9.93%
ROICexc(3y)11.54%
ROICexc(5y)11.73%
ROICexgc(3y)46.07%
ROICexgc(5y)42.74%
ROCE(3y)14.48%
ROCE(5y)14.24%
ROICexgc growth 3Y-10.89%
ROICexgc growth 5Y27.11%
ROICexc growth 3Y-24.53%
ROICexc growth 5Y9.97%
OM growth 3Y-8.1%
OM growth 5Y3.31%
PM growth 3Y-22.43%
PM growth 5Y-20.41%
GM growth 3Y6.09%
GM growth 5Y-1.57%
F-Score6
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 5.95
Debt/EBITDA 2.3
Cap/Depr 40.34%
Cap/Sales 4.3%
Interest Coverage 5.8
Cash Conversion 52.35%
Profit Quality 105.58%
Current Ratio 1.28
Quick Ratio 0.97
Altman-Z 2.21
F-Score6
WACC8.52%
ROIC/WACC0.88
Cap/Depr(3y)55.83%
Cap/Depr(5y)55.63%
Cap/Sales(3y)4.78%
Cap/Sales(5y)4.87%
Profit Quality(3y)143.88%
Profit Quality(5y)138.86%
High Growth Momentum
Growth
EPS 1Y (TTM)24.03%
EPS 3Y-11.06%
EPS 5Y1.06%
EPS Q2Q%-17.92%
EPS Next Y1.34%
EPS Next 2Y-1.16%
EPS Next 3Y-2.35%
EPS Next 5Y-5.87%
Revenue 1Y (TTM)3.9%
Revenue growth 3Y-7.84%
Revenue growth 5Y9.1%
Sales Q2Q%-5.92%
Revenue Next Year-1.36%
Revenue Next 2Y-1.53%
Revenue Next 3Y-2.16%
Revenue Next 5Y-3.45%
EBIT growth 1Y-5.75%
EBIT growth 3Y-15.3%
EBIT growth 5Y12.71%
EBIT Next Year16.58%
EBIT Next 3Y4.11%
EBIT Next 5Y-0.68%
FCF growth 1Y26.86%
FCF growth 3Y-30.95%
FCF growth 5Y-0.32%
OCF growth 1Y8.59%
OCF growth 3Y-26.87%
OCF growth 5Y0.25%

PFIZER INC / PFE.DE FAQ

What is the ChartMill fundamental rating of PFIZER INC (PFE.DE) stock?

ChartMill assigns a fundamental rating of 4 / 10 to PFE.DE.


Can you provide the valuation status for PFIZER INC?

ChartMill assigns a valuation rating of 7 / 10 to PFIZER INC (PFE.DE). This can be considered as Undervalued.


What is the profitability of PFE stock?

PFIZER INC (PFE.DE) has a profitability rating of 5 / 10.


What are the PE and PB ratios of PFIZER INC (PFE.DE) stock?

The Price/Earnings (PE) ratio for PFIZER INC (PFE.DE) is 7.96 and the Price/Book (PB) ratio is 1.56.


How financially healthy is PFIZER INC?

The financial health rating of PFIZER INC (PFE.DE) is 3 / 10.